BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8316003)

  • 1. [Myelodysplastic syndromes. Results from a prolonged follow-up].
    Rådlund A; Hansen S; Carlsson M; Stoméus S; Andreeva P; Jarlsfelt I; Thiede T; Engquist L
    Lakartidningen; 1993 Jun; 90(24):2299-301. PubMed ID: 8316003
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myelodysplastic syndromes].
    Ann Biol Clin (Paris); 1985; 43(4):369-79. PubMed ID: 4091300
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case from practice (112). Patient: Mrs. O. Z., born 1955].
    Fritschi J
    Schweiz Rundsch Med Prax; 1988 Aug; 77(31-32):830-2. PubMed ID: 3175416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deoxyuridine suppression test. A modified method and specificity in megaloblastic anemia].
    Yamauchi H; Iwata N; Karasawa M; Yatabe H; Tsukamoto N; Katahira H; Sugita Y; Omine M; Maekawa T
    Rinsho Ketsueki; 1987 Sep; 28(9):1517-21. PubMed ID: 3437512
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clarification of possible anemia].
    Uprichard J; Bain BJ
    Praxis (Bern 1994); 2009 Dec; 98(24):1453-5. PubMed ID: 19953471
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chromosomal structural changes in patients with myelodysplastic syndrome].
    Yu Y; Liu XP; Liu SH; Yu MH; Zhang Y; Xiao ZJ
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2693-7. PubMed ID: 18167247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myelodysplastic syndromes].
    Aul C; Germing U
    Internist (Berl); 1998 Nov; 39(11):1168-80. PubMed ID: 9859051
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prognostic factors in myelodysplastic syndromes].
    Scio P; Guarino P; Geniram A; Nosella D; Venturino M; Aversa A; Marini U
    Recenti Prog Med; 1988 Jan; 79(1):1-6. PubMed ID: 3375537
    [No Abstract]   [Full Text] [Related]  

  • 9. Histological and cytogenetic characterization of bone marrow in relation to prognosis and diagnosis of myelodysplastic syndromes.
    Sakuma T; Hayashi Y; Kanomata N; Murayama T; Matsui T; Kajimoto K; Hanioka K; Chihara K; Maeda S
    Pathol Int; 2006 Apr; 56(4):191-9. PubMed ID: 16634964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant methylation of GTPase regulator associated with the focal adhesion kinase (GRAF) promoter is an adverse prognostic factor in myelodysplastic syndrome.
    Qian J; Qian Z; Lin J; Yao DM; Zhu ZH; Chen Q; Xiao GF; Li JY
    Eur J Haematol; 2010 Aug; 85(2):174-6. PubMed ID: 20374274
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prognostic value of a modified WPSS based on routine laboratory parameters in patients with myelodysplastic syndromes: a preliminary result].
    Li L; Nie L; Yu MH; Yu Y; Liu L; Qin TJ; Xu ZF; Zhang Y; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 May; 30(5):313-7. PubMed ID: 19799126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives in the prognostication of myelodysplastic syndromes.
    Germing U; Kuendgen A
    Haematologica; 2005 Sep; 90(9):1157-9. PubMed ID: 16154836
    [No Abstract]   [Full Text] [Related]  

  • 13. Copper deficiency mimicking myelodysplastic syndrome.
    Rady K; Westerman D; Blombery P; Turner P; Seymour J
    Leuk Lymphoma; 2016 May; 57(5):1223-6. PubMed ID: 26693885
    [No Abstract]   [Full Text] [Related]  

  • 14. Oncogene mutation and prognosis in the myelodysplastic syndromes.
    Padua RA; West RR
    Br J Haematol; 2000 Dec; 111(3):873-4. PubMed ID: 11122149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypocellular myelodysplastic syndrome presenting as megaloblastic anemia.
    Ishtiaq O; Zahid M; Baqai H; Umer M; Shoaib A; Bashir K
    J Ayub Med Coll Abbottabad; 2002; 14(3):29-30. PubMed ID: 12476862
    [No Abstract]   [Full Text] [Related]  

  • 16. Increase of immature reticulocyte fraction in myelodysplastic syndromes.
    Lesesve JF; Daliphard S; Callat MP; Lenormand B
    Clin Lab Haematol; 2004 Aug; 26(4):301-2. PubMed ID: 15279670
    [No Abstract]   [Full Text] [Related]  

  • 17. [Frequent transformation to overt myelodysplastic syndrome in patients with aplastic anemia showing hematopoietic monoclonality at onset].
    Murai K; Numaoka H
    Rinsho Ketsueki; 2000 May; 41(5):391-6. PubMed ID: 10879097
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myelodysplastic syndrome in the county of Jönköping--a study of 50 cases 1978-1983].
    Hansen S; Carlsson M; Engquist L; Nielsen B; Rorsman G; Stoméus S; Thiede T; Zetterlund B
    Lakartidningen; 1985 Oct; 82(43):3707-9. PubMed ID: 4058142
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cytogenetic study of 93 myelodysplastic syndromes].
    Solé F; Woessner S; Florensa L; Pérez-Losada A; Acín P; Besses C; García-Eroles L; Sans-Sabrafen J
    Med Clin (Barc); 1998 Jan; 110(3):94-8. PubMed ID: 9534140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myelodysplastic syndromes: approaches to these difficult to understand].
    Tohyama K
    Rinsho Ketsueki; 2006 Mar; 47(3):167-75. PubMed ID: 16629481
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.